种植体设计与修复体特征与药物相关性颌骨坏死关联分析
本研究回顾性分析67例患者共355枚种植体,其中112枚发生药物相关性颌骨坏死(MRONJ),243枚未发生。结果显示外部连接型种植体、种植体周围炎、组织水平种植体的凸形穿龈轮廓及骨水平种植体修复体穿龈角>30°与MRONJ风险升高相关,提示种植体设计及修复体特征可能影响MRONJ发生。
要点
- 外部连接型种植体较组织水平种植体MRONJ风险更高(OR 4.07)。
- 合并种植体周围炎者MRONJ风险显著升高(OR 7.43)。
- 组织水平种植体凸形轮廓、骨水平种植体穿龈角>30°与MRONJ相关。
核心结论
- 种植体颈部设计可能与MRONJ发生相关,修复体特征对MRONJ的影响因种植体设计而异。
- 接受抗骨吸收治疗的患者应审慎规划种植体设计并考虑解剖位置以降低MRONJ风险。
研究设计与样本
- 回顾性研究,纳入2008年1月至2022年3月延世大学牙科医院67例患者共355枚种植体,每例至少1枚种植体发生MRONJ。
- 采用广义估计方程模型校正患者内聚类效应。
主要发现
- 355枚种植体中112枚发生MRONJ,243枚未发生。
- 外部连接型种植体MRONJ风险高于组织水平种植体(OR 4.07;95%CI 1.23-13.45)。
- 合并种植体周围炎的种植体MRONJ风险高于无种植体周围炎者(OR 7.43;95%CI 2.74-20.14)。
- 组织水平种植体中凸形轮廓者MRONJ发生率为39.1%,直形或凹形轮廓者为15.8%。
- 骨水平种植体中,至少一侧穿龈角>30°的修复体MRONJ发生率显著高于双侧穿龈角≤30°者。
关键数值与推荐
- 外部连接型种植体vs组织水平种植体MRONJ的OR为4.07(95%CI 1.23-13.45)。
- 种植体周围炎vs无种植体周围炎MRONJ的OR为7.43(95%CI 2.74-20.14)。
- 组织水平种植体凸形轮廓MRONJ发生率39.1%,直形或凹形轮廓为15.8%。
- 骨水平种植体至少一侧穿龈角>30°的修复体MRONJ风险高于双侧≤30°者。
临床怎么用
- 接受抗骨吸收治疗的患者种植治疗规划时应考虑种植体颈部设计。
- 磨牙区等解剖高风险区域应关注穿龈角及穿龈轮廓对MRONJ风险的影响。
- 对合并种植体周围炎的患者应加强监控,因其MRONJ风险显著升高。
局限性
- 回顾性研究设计,仅纳入单中心每例至少1枚种植体发生MRONJ的患者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to identify risk factors associated with medication-related osteonecrosis of the jaw (MRONJ) around dental implants, focusing on implant/prosthesis characteristics and peri-implantitis. METHODS: This retrospective study included 355 dental implants obtained from 67 patients, each with at least one implant affected by MRONJ, who visited Yonsei University Dental Hospital between January 2008 and March 2022. The outcome variable was the presence or absence of MRONJ. Predictor variables included implant location, crestal module design, prosthesis type, emergence profile, emergence angle (EA), and peri-implantitis. A generalized estimating equation model was used to adjust for within-patient clustering effects. RESULTS: A total of 355 implants were analyzed, of which 112 implants were affected by MRONJ and 243 were not affected. External-type implants had higher odds of MRONJ than tissue-level implants (OR, 4.07; 95 % CI, 1.23-13.45). The odds of MRONJ were higher in implants with peri-implantitis compared to those without peri-implantitis (OR, 7.43; 95 % CI, 2.74-20.14). In tissue-level implants, MRONJ was significantly associated with a convex profile (39.1 %) than in those with straight or concave profiles (15.8 %). In bone-level implants, MRONJ was significantly higher in prostheses with an EA of >30º on at least one side, compared to those with EA of ≤30º on both sides. In addition, implants placed in the molar region had a significantly wider EA and more frequent convex profiles than those placed in the premolar region. CONCLUSIONS: MRONJ affected dental implants may be associated with crestal module design. In addition, implant prosthesis characteristics may influence MRONJ occurrence depending on the implant design, and in patients receiving antiresorptive therapy, implant design should be carefully planned with consideration of the anatomical location to minimize the risk of MRONJ. CLINICAL SIGNIFICANCE: Implant design should be considered when planning implant treatment in patients receiving antiresorptive therapy, especially in anatomically vulnerable areas such as the molar region.
引用
- Kim J, Kim JY, Choi EJ, et al. Is medication-related osteonecrosis of the jaw around dental implants associated with the implant design and prosthesis characteristics? J Dent. 2025. PMID: 41005639. doi:10.1016/j.jdent.2025.106133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。